{"id":52113,"date":"2025-04-25T15:57:08","date_gmt":"2025-04-25T15:57:08","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/52113\/"},"modified":"2025-04-25T15:57:08","modified_gmt":"2025-04-25T15:57:08","slug":"la-revue-prescrire-alerte-sur-les-medicaments-prescrits-contre-les-brulures-destomac-et-les-remontees-acides","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/52113\/","title":{"rendered":"La revue \u00ab\u00a0Prescrire\u00a0\u00bb alerte sur les m\u00e9dicaments prescrits contre les br\u00fblures d\u2019estomac et les remont\u00e9es acides"},"content":{"rendered":"<p>Prescrits pour soulager br\u00fblures d\u2019estomac, reflux acides ou ulc\u00e8res, les inhibiteurs de la pompe \u00e0 protons (IPP) sont devenus incontournables dans l\u2019arsenal th\u00e9rapeutique. Om\u00e9prazole, pantoprazole, \u00e9som\u00e9prazole\u2026 Pr\u00e8s de 20\u00a0millions de Fran\u00e7ais consommeraient ces <a href=\"https:\/\/www.20minutes.fr\/dossier\/medicament\" class=\"color-ultramarine c-link\" rel=\"nofollow noopener\" target=\"_blank\">m\u00e9dicaments<\/a> chaque ann\u00e9e. Mais cet usage massif, souvent prolong\u00e9, suscite une inqui\u00e9tude croissante dans la communaut\u00e9 m\u00e9dicale. La revue ind\u00e9pendante <a href=\"https:\/\/www.prescrire.org\/effets-indesirables\/498-ipp-au-long-cours-surcroit-de-cancers-gastriques-et-de-recidives\" rel=\"nofollow noopener\" target=\"_blank\" class=\"color-ultramarine c-link\">Prescrire<\/a> alerte m\u00eame, dans son dernier num\u00e9ro, sur un potentiel lien entre les IPP et le <a href=\"https:\/\/www.20minutes.fr\/dossier\/cancer\" class=\"color-ultramarine c-link\" rel=\"nofollow noopener\" target=\"_blank\">cancer<\/a> de l\u2019estomac. \u00ab\u00a0D\u00e8s les ann\u00e9es\u00a01980, des \u00e9tudes animales montraient un risque accru de tumeurs gastriques b\u00e9nignes\u00a0\u00bb, souligne Jean-Luc Raoul, oncologue, interrog\u00e9 par <a href=\"https:\/\/sante.lefigaro.fr\/medecine\/les-medicaments-contre-l-acidite-gastrique-provoquent-ils-des-cancers-de-l-estomac-20250425\" rel=\"nofollow noopener\" target=\"_blank\" class=\"color-ultramarine c-link\">Le Figaro<\/a>.<\/p>\n<p>En\u00a02017, avec une \u00e9tude portant sur plus de 350.000 patients a r\u00e9v\u00e9l\u00e9 une surmortalit\u00e9 de 25\u00a0% chez les utilisateurs chroniques d\u2019IPP par rapport aux patients trait\u00e9s par antihistaminiques H2. Puis, en\u00a02023, deux recherches ont identifi\u00e9 un risque quadrupl\u00e9 de cancer de l\u2019estomac ayant pris des IPP plus de six mois.<\/p>\n<\/p>\n<p>Toutefois, la raret\u00e9 des cas de cancer gastrique rend difficile l\u2019\u00e9tude du lien entre celui-ci et les IPP. Mais leur usage prolong\u00e9 comporte d\u2019autres risques\u00a0: <a href=\"https:\/\/www.20minutes.fr\/dossier\/infection\" class=\"color-ultramarine c-link\" rel=\"nofollow noopener\" target=\"_blank\">infections<\/a>, carences, fractures\u2026 Face \u00e0 ces donn\u00e9es, la prudence s\u2019impose. Seule difficult\u00e9, l\u2019arr\u00eat de ces traitements conduit parfois \u00e0 des effets rebonds, avec le retour des reflux gastriques par exemple, ce qui conduit parfois \u00e0 de nouvelles prescriptions d\u2019IPP.<\/p>\n","protected":false},"excerpt":{"rendered":"Prescrits pour soulager br\u00fblures d\u2019estomac, reflux acides ou ulc\u00e8res, les inhibiteurs de la pompe \u00e0 protons (IPP) sont&hellip;\n","protected":false},"author":2,"featured_media":52114,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[47,101,1011,27,72,13849,225,71],"class_list":{"0":"post-52113","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-actualite","9":"tag-cancer","10":"tag-fr","11":"tag-france","12":"tag-health","13":"tag-infection","14":"tag-medicament","15":"tag-sante"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/114399428445397100","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/52113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=52113"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/52113\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/52114"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=52113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=52113"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=52113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}